Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Troubling Findings in Study of GLP-1 Compounders

Summary by MedPage Today
(MedPage Today) -- The market for compounded GLP-1 drugs remained robust despite the end of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating...

1 Articles

MedPage TodayMedPage Today
Center

Troubling Findings in Study of GLP-1 Compounders

(MedPage Today) -- The market for compounded GLP-1 drugs remained robust despite the end of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating...

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Monday, July 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Ozempic icon

Ozempic

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal